SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-083592
Filing Date
2019-03-22
Accepted
2019-03-22 16:32:32
Documents
2
Group Members
BLACKSTONE CLARUS II L.L.C.BLACKSTONE GROUP L.P.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP INC.BLACKSTONE HOLDINGS II L.P.CLARUS VENTURES II GP, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO SCHEDULE 13D d701189dsc13da.htm SC 13D/A 153807
2 EX-99.1 d701189dex991.htm EX-99.1 11337
  Complete submission text file 0001193125-19-083592.txt   166958
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Subject) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87534 | Film No.: 19700269
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Filed by) CIK: 0001431443 (see all company filings)

IRS No.: 261856183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A